Overview
ASO Visual Abstract: Limited Benefit of Adjuvant Chemotherapy in Pathological Stage II-III Non-small-cell Lung Cancer Lacking Lymphatic, Vascular, and Pleural Invasion.
Written by:
Full abstract not available! Read the article on the external site for details.
